S32 Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 9

Professionals

  • Investments
  • 139

  • Portfolio
  • 79

  • Exits
  • 23

Exits

S32 General Information

Description

Founded in 2017, S32 is a venture capital firm and is based in Los Altos, California. The firm invests across the technology sector which includes artificial intelligence, enterprise software, cybersecurity, fintech, quantum computing, computational biology, and biotechnology.

Contact Information

Website
www.s32.com
Year Founded
2017
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 169 University Avenue
  • Palo Alto, CA 94301
  • United States
+1 (650) 000-0000

S32 Investments (139)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
ROME Therapeutics 12-Sep-2023 Early Stage VC 00000 Drug Discovery Pre-Clinical Trials 000000 00000 00.0
00000 0000 03-Aug-2023 00000 00000 0000 Business/Productivity Software Generating Revenue
000000 26-Jul-2023 00000 00000 0000 Decision/Risk Analysis Generating Revenue 0000000 0000000 00
000000 22-Jun-2023 00000 00000 000.00 Drug Discovery Pre-Clinical Trials 0000000 0000000 00
00000 00 01-Apr-2023 00000 00000 Business/Productivity Software Generating Revenue
0000 08-Feb-2023 00000 00000 0000 Enterprise Systems (Healthcare) Generating Revenue 000000 00000000
00000000 25-Jan-2023 00000 00000 000.00 Network Management Software Generating Revenue
0000000 00000000 24-Jan-2023 00000 00000 0000 Business/Productivity Software Generating Revenue
Delve Bio 04-Jan-2023 Early Stage VC 000.00 Biotechnology Startup
Port Therapeutics 14-Oct-2022 Early Stage VC Drug Discovery Startup
You’re viewing 10 of 139 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

S32 Exits (23)

Company Name Exit Date Exit Type Exit Size
Glympse Bio 09-Aug-2023 Merger/Acquisition
000000 01-May-2023 000 00 00000000
000000000 15-Mar-2023 000000000000000000
0000000 19-May-2022 0000000000
0000 04-Jan-2022 0000000 000000 00000
0000 17-Dec-2021 0000000 000000 00.00
0000000 000000 02-Nov-2021 000000000000000000 00000
0000000 30-Sep-2021 000000000000000000 00000
Cue Health 24-Sep-2021 IPO 00000
Ciitizen 14-Sep-2021 Merger/Acquisition 00000
You’re viewing 10 of 23 exits. Get the full list »

S32 Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

S32 Team (21)

Name Title Deals Funds Boards Office
Andrew Harrison Managing Partner & Chief Executive Officer 0 0 0 Palo Alto, CA
Nina Labatt Chief Operating Officer & Chief Financial Officer 0 Palo Alto, CA
Michael Pellini MD Managing Partner 00 0 00 Palo Alto, CA
Steven Kafka Ph.D Managing Partner 0 0 0 Palo Alto, CA
Ainhoa Maiz Senior Principal 0 Palo Alto, CA
You’re viewing 5 of 21 team members. Get the full list »

S32 Co-Investors (626)

Name With Exits Lead Partner Series Industry
Casdin Capital 14 0 0 Series chart Industry bar
Alexandria Venture Investments 00 0 0 Series chart Industry bar
Andreessen Horowitz 00 0 0 Series chart Industry bar
GV 00 0 0 Series chart Industry bar
ARCH Venture Partners 0 0 0 Series chart Industry bar
You’re viewing 5 of 626 co-investors. Get the full list »